Literature DB >> 25384351

Atypical femoral fracture in osteoporosis pseudoglioma syndrome associated with two novel compound heterozygous mutations in LRP5.

Nerea Alonso1, Dinesh C Soares, Eugene V McCloskey, Gregory D Summers, Stuart H Ralston, Celia L Gregson.   

Abstract

Osteoporosis pseudoglioma syndrome (OPPG) is a rare autosomal recessive condition of congenital blindness and severe childhood osteoporosis with skeletal fragility, caused by loss-of-function mutations in the low-density lipoprotein receptor-related protein 5 (LRP5) gene. We report the first case of atypical (subtrochanteric) femoral fracture (AFF) in OPPG, occurring in a 38-year-old man within the context of relatively low bone turnover and trabecular osteoporosis on bone histology. We identify two novel LRP5 mutations: R752W is associated with low bone mineral density (BMD), as demonstrated by the heterozygous carriage identified in his 57-year-old mother; however, the combination of this R752W mutation with another novel W79R mutation, causes a severe case of compound heterozygous OPPG. We undertake 3D homology modeling of the four extracellular YWTD β-propeller/EGF-like domains (E1-E4) of LRP5, and show that both novel mutations destabilize the β-propeller domains that are critical for protein and ligand binding to regulate Wnt signaling and osteoblast function. Although AFFs have been reported in other rare bone diseases, this is the first in a genetic condition of primary osteoblast dysfunction. The relatively low bone turnover observed, and knowledge of LRP5 function, implicates impaired bone remodeling in the pathogenesis of AFF.
© 2014 American Society for Bone and Mineral Research.

Entities:  

Keywords:  ATYPICAL FEMORAL FRACTURE; COMPOUND HETEROZYGOTE; LRP5; OPPG; PROTEIN MODEL

Mesh:

Substances:

Year:  2015        PMID: 25384351     DOI: 10.1002/jbmr.2403

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  11 in total

1.  Fractures on bisphosphonates in osteoporosis pseudoglioma syndrome (OPPG): pQCT shows poor bone density and structure.

Authors:  Elizabeth A Streeten; Sheila Ramirez; Myrto Eliades; Sarada Jaimungal; Sruti Chandrasekaran; Ryan Kathleen; D Holmes Morton; Erik G Puffenberger; Rita Herskovitz; Mary B Leonard
Journal:  Bone       Date:  2015-04-16       Impact factor: 4.398

2.  Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG).

Authors:  M Celli; P D'Eufemia; P Persiani; A Turchetti; A Febbo; Y D'Alfonso; L Celli; A Zambrano
Journal:  Osteoporos Int       Date:  2017-09-02       Impact factor: 4.507

Review 3.  Value of rare low bone mass diseases for osteoporosis genetics.

Authors:  Alice Costantini; Outi Mäkitie
Journal:  Bonekey Rep       Date:  2016-01-06

4.  Osteoporosis-Pseudoglioma in a Mauritanian Child due to a Novel Mutation in LRP5.

Authors:  Noura Biha; S M Ghaber; M M Hacen; Corinne Collet
Journal:  Case Rep Genet       Date:  2016-01-19

5.  Presence of pyrophosphate in bone from an atypical femoral fracture site: A case report.

Authors:  Maziar Shabestari; Erik Fink Eriksen; Eleftherios P Paschalis; Paul Roschger; Sonja Gamsjaeger; Klaus Klaushofer; Andrea Berzlanovich; Xavier Nogues; Lluis Puig; Adolfo Diez-Perez
Journal:  Bone Rep       Date:  2017-03-02

6.  Effect of Sleeve Gastrectomy on Bone Metabolism and Serum 5-Hydroxytryptamine in Obese Rats.

Authors:  Kai Xu; Junxing Ma; Zhi Liu; Xiaoyang Wang; Shaohua Yan; Zitian Liu; Fuyun Sun; Kexin Wang
Journal:  Med Sci Monit       Date:  2020-04-23

7.  Mutations in Known Monogenic High Bone Mass Loci Only Explain a Small Proportion of High Bone Mass Cases.

Authors:  Celia L Gregson; Lawrie Wheeler; Sarah A Hardcastle; Louise H Appleton; Kathryn A Addison; Marieke Brugmans; Graeme R Clark; Kate A Ward; Margaret Paggiosi; Mike Stone; Joegi Thomas; Rohan Agarwal; Kenneth E S Poole; Eugene McCloskey; William D Fraser; Eleanor Williams; Alex N Bullock; George Davey Smith; Matthew A Brown; Jon H Tobias; Emma L Duncan
Journal:  J Bone Miner Res       Date:  2015-10-06       Impact factor: 6.741

Review 8.  Genetic Risk Factors for Atypical Femoral Fractures (AFFs): A Systematic Review.

Authors:  Hanh H Nguyen; Denise M van de Laarschot; Annemieke JMH Verkerk; Frances Milat; M Carola Zillikens; Peter R Ebeling
Journal:  JBMR Plus       Date:  2018-01-03

Review 9.  The Genetic Architecture of High Bone Mass.

Authors:  Celia L Gregson; Emma L Duncan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-29       Impact factor: 5.555

10.  Gene Network of Susceptibility to Atypical Femoral Fractures Related to Bisphosphonate Treatment.

Authors:  Natalia Garcia-Giralt; Neus Roca-Ayats; Josep F Abril; Nuria Martinez-Gil; Diana Ovejero; Santos Castañeda; Xavier Nogues; Daniel Grinberg; Susanna Balcells; Raquel Rabionet
Journal:  Genes (Basel)       Date:  2022-01-14       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.